Massimo Galli
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 0.1%
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 77
- HIV/AIDS Research and Interventions 32
- COVID-19 Clinical Research Studies 29
- SARS-CoV-2 and COVID-19 Research 24
- Epidemiology 101
- Hepatitis B Virus Studies 30
- Co-authors
- Spinello Antinori (59 shared papers)Mauro Moroni (55 shared papers)Gianguglielmo Zehender (57 shared papers)Laura Milazzo (37 shared papers)Anna Lisa Ridolfo (42 shared papers)Tiziano Barbui (6 shared papers)Claudia Balotta (36 shared papers)Cristina Gervasoni (39 shared papers)
- Journals
- AIDS (25 papers)AIDS Research and Human Retroviruses (18 papers)Antiviral Therapy (17 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (15 papers)PLoS ONE (14 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Massimo Galli
482 papers receiving 12.9k citations
Massimo Galli's Hit Papers
Peers
Comparison fields: 5 of 186
- Virology 2.1k
- Infectious Diseases 4.4k
- Hepatology 1.3k
- Emergency Medicine 1.2k
- Rheumatology 1.3k
Countries citing papers authored by Massimo Galli
This map shows the geographic impact of Massimo Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Galli more than expected).
Fields of papers citing papers by Massimo Galli
This network shows the impact of papers produced by Massimo Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Galli. The network helps show where Massimo Galli may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Galli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 498 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study Hit paper breakdown → | 2020 | 918 |
| 2 | Lupus Anticoagulant IgG's (LA) Are Not Directed to Phospholipids only, but to a Complex of Lipid-Bound Human Prothrombin Hit paper breakdown → | 1991 | 484 |
| 3 | Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC Hit paper breakdown → | 2019 | 420 |
| 4 | 2020 | 333 | |
| 5 | 1999 | 263 | |
| 6 | 1995 | 205 | |
| 7 | A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis Hit paper breakdown → | 2019 | 203 |
| 8 | 2016 | 193 | |
| 9 | Retinal findings in patients with COVID-19: Results from the SERPICO-19 study Hit paper breakdown → | 2020 | 190 |
| 10 | 2005 | 157 | |
| 11 | Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi's sarcoma patients. | 1997 | 157 |
| 12 | 2020 | 155 | |
| 13 | 2020 | 154 | |
| 14 | 2011 | 152 | |
| 15 | 2020 | 147 | |
| 16 | 2017 | 143 | |
| 17 | 2014 | 141 | |
| 18 | 2002 | 130 | |
| 19 | 1995 | 126 | |
| 20 | 2020 | 125 |
About Massimo Galli
Massimo Galli is a scholar working on Infectious Diseases, Epidemiology, Virology, Hepatology and Immunology, having authored 498 papers that have together received 13.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (90 papers), HIV/AIDS drug development and treatment (77 papers), Hepatitis C virus research (61 papers), HIV-related health complications and treatments (41 papers), HIV/AIDS Research and Interventions (32 papers), Hepatitis B Virus Studies (30 papers), COVID-19 Clinical Research Studies (29 papers) and SARS-CoV-2 and COVID-19 Research (24 papers). The work is most often cited by research in Virology (2.1k citations), Infectious Diseases (4.4k citations), Hepatology (1.3k citations), Emergency Medicine (1.2k citations) and Rheumatology (1.3k citations). Massimo Galli has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Spinello Antinori, Mauro Moroni, Gianguglielmo Zehender, Laura Milazzo, Anna Lisa Ridolfo, Tiziano Barbui, Claudia Balotta, Cristina Gervasoni, Alessia Lai and Paul Comfurius. Their work appears in journals such as AIDS, AIDS Research and Human Retroviruses, Antiviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.